Andrea Barrio (@andreabarrio7) 's Twitter Profile
Andrea Barrio

@andreabarrio7

ID: 1112446698142515200

calendar_today31-03-2019 20:08:55

177 Tweet

204 Takipçi

96 Takip Edilen

SABCS (@sabcssanantonio) 's Twitter Profile Photo

Monica Morrow, MD, will moderate an #SABCS24 session about axillary staging in ER-positive breast cancer on Thursday. Learn more in SABCS Meeting News: bit.ly/3ZwP7JN

Monica Morrow, MD, will moderate an #SABCS24 session about axillary staging in ER-positive breast cancer on Thursday. Learn more in SABCS Meeting News: 
bit.ly/3ZwP7JN
SABCS (@sabcssanantonio) 's Twitter Profile Photo

Sarah McLaughlin, Yvonne Florance, Stephanie Wong, and Atif Khan discussed "Optimizing Local Therapy" in an #SABCS24 educational session moderated by Tari King. Atif J Khan @stephaniemwong Tari King MD

Sarah McLaughlin, Yvonne Florance, Stephanie Wong, and Atif Khan discussed "Optimizing Local Therapy" in an #SABCS24 educational session moderated by Tari King. 
<a href="/theRADSofKHAN/">Atif J Khan</a> @stephaniemwong <a href="/TariKingMD/">Tari King MD</a>
JAMA (@jama_current) 's Twitter Profile Photo

In this Editorial, Monica Morrow and Andrea Barrio discuss the COMET trial of active monitoring of women with DCIS, putting the findings in clinical context and calling for longer follow-up and more research. #SABCS24 SABCS

In this Editorial, Monica Morrow and <a href="/AndreaBarrio7/">Andrea Barrio</a> discuss the COMET trial of active monitoring of women with DCIS, putting the findings in clinical context and calling for longer follow-up and more research.

#SABCS24 <a href="/SABCSSanAntonio/">SABCS</a>
Elisabetta Bonzano MD, PhD (@to_be_elizabeth) 's Twitter Profile Photo

📌 Clinical Controversies: Omission of Axillary Staging in ER Positive Breast Cancer: Implications on Adjuvant Therapies Topic 1: Omission of Axillary Staging in ER+ Disease – What is The Data? by Dr. E Mittendorf Dana-Farber’s Breast Oncology Center #SABCS24 #day3 OncoAlert #OncoAlertAF

📌 Clinical Controversies: Omission of Axillary Staging in ER Positive Breast Cancer: Implications on Adjuvant Therapies
Topic 1: Omission of Axillary Staging in ER+ Disease – What is The Data? by 
<a href="/EMittendorfMD/">Dr. E Mittendorf</a> <a href="/DFCI_BreastOnc/">Dana-Farber’s Breast Oncology Center</a> 
#SABCS24 #day3 <a href="/OncoAlert/">OncoAlert</a> #OncoAlertAF
SABCS (@sabcssanantonio) 's Twitter Profile Photo

Elizabeth Mittendorf, Jean Wright, Kevin Kalinsky, and Richard Zellars addressed this topic in an #SABCS24 Clinical Controversies session moderated by Monica Morrow. Dr. E Mittendorf Jean Wright, MD MBA Kevin Kalinsky, MD, MS, FASCO

Elizabeth Mittendorf, Jean Wright, Kevin Kalinsky, and Richard Zellars addressed this topic in an #SABCS24 Clinical Controversies session moderated by Monica Morrow. <a href="/EMittendorfMD/">Dr. E Mittendorf</a> <a href="/drjeanwright/">Jean Wright, MD MBA</a> <a href="/KalinskyKevin/">Kevin Kalinsky, MD, MS, FASCO</a>
Kevin W. (@brink_thinker) 's Twitter Profile Photo

This Pennsylvania barbershop is helping children build their confidence, paying young customers $3 to read stories aloud while getting a haircut deserves unlimited retweets..

CancerNetwork® (@cancernetwrk) 's Twitter Profile Photo

🚨 New manuscript alert from Drs Anita Mamtani and Andrea Barrio on surgical management in the axilla for patients with breast cancer. #bcsm | Andrea Barrio Neil Iyengar Memorial Sloan Kettering Cancer Center cancernetwork.com/view/updates-i…

SGBCC (@sg_bcc) 's Twitter Profile Photo

Great first day at #SGBCC2025🌟 Share your favorite moments in the comments and tag #SGBCC2025 for a chance to be featured on our social wall. See you tomorrow for Day 2! 👋 #BreastCancerResearch #BreastCancerAwareness #FromResearchToPractice #Vienna

Great first day at #SGBCC2025🌟

Share your favorite moments in the comments and tag #SGBCC2025 for a chance to be featured on our social wall. See you tomorrow for Day 2! 👋 

#BreastCancerResearch #BreastCancerAwareness #FromResearchToPractice #Vienna
PennSurgery (@pennsurgery) 's Twitter Profile Photo

Jennifer Zhang, MD has been named a recipient for the National Comprehensive Cancer Network Foundation Young Investigator Awards Program. These early-career investigators from National Comprehensive Cancer Network (NCCN) Member Institutions represent tomorrow’s leaders for advancing cancer care.  CONGRATULATIONS!!!

Jennifer Zhang, MD has been named a recipient for the National Comprehensive Cancer Network Foundation Young Investigator Awards Program. These early-career investigators from <a href="/NCCN/">National Comprehensive Cancer Network (NCCN)</a> Member Institutions represent tomorrow’s leaders for advancing cancer care.  CONGRATULATIONS!!!
Eliza Hersh Lorentzen, MD (@eliza_lorentzen) 's Twitter Profile Photo

Great turnout for the Resident & Fellow Track session “Becoming a Surgical Oncologist: What Trainees Should Know for a Successful Match.” Stephanie Downs-Canner kicking it off with insight into the breast application process. Happening now in rm 124! Marissa Boyle Chris Childers

Great turnout for the Resident &amp; Fellow Track session “Becoming a Surgical Oncologist: What Trainees Should Know for a Successful Match.” <a href="/SDownsCanner/">Stephanie Downs-Canner</a> kicking it off with insight into the breast application process. Happening now in rm 124!

<a href="/MkBoyleMD/">Marissa Boyle</a> 
<a href="/cchildersmd/">Chris Childers</a>
Olga Kantor MD, MS, FACS (@okantormd) 's Twitter Profile Photo

Dr. Anita Mamtani presents the Memorial Sloan Kettering Cancer Center prospective trial of SLNB for limited nodal burden in setting of a palp node Society of Surgical Oncology - feasible in well selected pts with no axillary recurrences to date at 1 year. Palp guided excision key to success. Intriguing data! #SSO2025

Dr. Anita Mamtani presents the <a href="/MSKCancerCenter/">Memorial Sloan Kettering Cancer Center</a> prospective trial of SLNB for limited nodal burden in setting of a palp node <a href="/SocSurgOnc/">Society of Surgical Oncology</a> - feasible in well selected pts with no axillary recurrences to date at 1 year. Palp guided excision key to success. Intriguing data! 
#SSO2025
Olga Kantor MD, MS, FACS (@okantormd) 's Twitter Profile Photo

Dr. Giacomo Montagna presents the microNAC international collab - 30% of pts with residual micromets after chemo have add’l disease, although this doesn’t translate into differences in axillary recurrence. TN subtype may be an exception Society of Surgical Oncology #SSO2025 Memorial Sloan Kettering Cancer Center

Dr. Giacomo Montagna presents the microNAC international collab - 30% of pts with residual micromets after chemo have add’l disease, although this doesn’t translate into differences in axillary recurrence. TN subtype may be an exception <a href="/SocSurgOnc/">Society of Surgical Oncology</a> #SSO2025 <a href="/MSKCancerCenter/">Memorial Sloan Kettering Cancer Center</a>
Olga Kantor MD, MS, FACS (@okantormd) 's Twitter Profile Photo

Excellent breast great debate topics and contenders! Split vote on omission of axillary surgery vs RT in low risk early BC, robotic nipple sparing mastectomy very intriguing but not ready for mainstream #SSO2025 Andrea Barrio Anna Weiss James Jakub Judy Boughey

Excellent breast great debate topics and contenders! Split vote on omission of axillary surgery vs RT in low risk early BC, robotic nipple sparing mastectomy very intriguing but not ready for mainstream #SSO2025 <a href="/AndreaBarrio7/">Andrea Barrio</a> <a href="/AnnaWeissMD/">Anna Weiss</a> <a href="/DrJamesJakub/">James Jakub</a> <a href="/DrJudyBoughey/">Judy Boughey</a>
OncoDaily (@oncodaily) 's Twitter Profile Photo

Inspiring presidential address by Ronald de Matteo at SSO2025 - Flavio G Rocha, MD, FACS, FSSO DeMatteoLab PennSurgery oncodaily.com/blog/ronald-de… #OncoDaily #Oncology #Cancer #Health #Medicine #MedTwitter #MedEd #MedOnc #MedNews #SSO2025

Inspiring presidential address by Ronald de Matteo at SSO2025 - <a href="/FlavioRochaMD/">Flavio G Rocha, MD, FACS, FSSO</a> 
<a href="/dematteo_lab/">DeMatteoLab</a> <a href="/pennsurgery/">PennSurgery</a>

oncodaily.com/blog/ronald-de…

#OncoDaily #Oncology #Cancer #Health #Medicine #MedTwitter #MedEd #MedOnc #MedNews #SSO2025
James Jakub (@drjamesjakub) 's Twitter Profile Photo

Very exciting a drug that treats menopausal symptoms may also decrease the risk of developing breast cancer. Can you say win - win. ASCO